K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar ChrisGraley (99.66) Submitted: 4/5/2011 11:37:14 PM : Outperform Start Price: $4.65 KV-A Score: -70.28

Alright, I''ve rode this up and then red thumbed it and rode it down. It's priced to be a good choice for the long run again.

Featured Broker Partners


Advertisement